Current Price and Development
The current price of Bayer stock is around 24.45 EUR, which represents a slight decrease of 0.02 EUR or 0.08% compared to the previous day. The stock has crossed the 200-day line upward, a positive signal for long-term investors. Since the initial downtrend starting May 14, 2025, the stock has regained momentum.
Company News
Particularly in the pharmaceuticals segment, Bayer has outperformed expectations, bringing positive surprises for investors. Despite challenges in the agricultural sector, the company remains optimistic for the year 2025.
Market Development
Although the overall market environment is weaker, Bayer stock has shown positive development. This underscores the strength and independence of the company from general market trends. While the DAX remained stable, Bayer stock surprised investors on May 13, 2025, with an increase of 10.95%.
Goals and Outlook for 2025
Bayer has confirmed its goals for 2025, despite a lower adjusted consolidated earnings per share (a decrease of 11.7% to 2.49 EUR). This decline is mainly due to weakness in the Crop Division. Nevertheless, Bayer remains optimistic, especially given the strong numbers from the pharmaceuticals segment.
Overall, Bayer stock appears robust despite a challenging market environment, attributed to the strength of the pharmaceuticals segment and positive market trends. The crossing of the 200-day line represents a positive signal and reaffirms the stability and growth potential of the company.